0,747  0,014  CYP3A4 substrate
0,696  0,021  Antineoplastic (breast cancer)
0,642  0,012  Antineoplastic (ovarian cancer)
0,640  0,031  Caspase 9 stimulant
0,610  0,004  Interleukin 6 antagonist
0,592  0,006  Antineoplastic (lymphoma)
0,625  0,047  Antiinflammatory
0,579  0,025  Antineoplastic (colorectal cancer)
0,576  0,024  Antineoplastic (colon cancer)
0,528  0,023  CYP2C19 substrate
0,526  0,025  Cognition disorders treatment
0,510  0,021  Antineoplastic (cervical cancer)
0,519  0,042  Antineoplastic (lung cancer)
0,490  0,017  Nitric oxide antagonist
0,504  0,035  CYP2C9 substrate
0,457  0,002  Progesterone antagonist
0,512  0,071  Apoptosis agonist
0,437  0,007  Antiviral (Influenza)
0,438  0,017  Antineoplastic (endocrine cancer)
0,427  0,013  UGT1A4 substrate
0,446  0,037  5 Hydroxytryptamine release stimulant
0,426  0,019  Potassium channel blocker
0,414  0,010  UGT2B7 substrate
0,415  0,013  Sodium/bile acid cotransporter inhibitor
0,429  0,030  ICAM1 expression inhibitor
0,429  0,032  Lipoprotein disorders treatment
0,407  0,014  Contraceptive
0,425  0,033  Cytotoxic
0,414  0,022  UGT1A6 substrate
0,415  0,027  UGT2B4 substrate
0,420  0,034  Antineoplastic (brain cancer)
0,425  0,040  Respiratory analeptic
0,407  0,037  NOS3 expression inhibitor
0,386  0,028  Hypolipemic
0,401  0,043  Hepatic disorders treatment
0,383  0,026  Antimitotic
0,366  0,012  Lipocortins synthesis antagonist
0,398  0,044  CYP2D6 substrate
0,387  0,044  AR expression inhibitor
0,353  0,011  Antiviral (Influenza A)
0,377  0,037  Cytostatic
0,359  0,022  UGT1A1 substrate
0,385  0,055  Prostate cancer treatment
0,381  0,055  Bone diseases treatment
0,327  0,005  ABCA1 expression enhancer
0,363  0,046  Antiosteoporotic
0,357  0,044  Antineoplastic (glioma)
0,346  0,041  Antihypoxic
0,368  0,064  Antiprotozoal (Plasmodium)
0,351  0,051  Analeptic
0,307  0,010  UGT2B9 substrate
0,333  0,041  Antineoplastic (renal cancer)
0,341  0,053  CYP1A2 substrate
0,320  0,033  Antineoplastic (sarcoma)
0,292  0,006  Contraceptive female
0,315  0,032  UDP-glucuronosyltransferase substrate
0,331  0,049  Antineoplastic (multiple myeloma)
0,296  0,019  Prostate disorders treatment
0,317  0,043  Angiogenesis stimulant
0,296  0,024  Prostatic (benign) hyperplasia treatment
0,280  0,011  Antineoplastic antibiotic
0,347  0,078  Transcription factor NF kappa B inhibitor
0,272  0,004  Antineoplastic alkaloid
0,272  0,004  Potassium channel (Ca-activated) blocker
0,321  0,054  UGT1A9 substrate
0,283  0,020  UGT2B15 substrate
0,357  0,096  TNF expression inhibitor
0,351  0,092  Antiprotozoal
0,303  0,046  Antineoplastic (glioblastoma multiforme)
0,304  0,051  Proliferative diseases treatment
0,314  0,063  Antineoplastic (pancreatic cancer)
0,325  0,076  Cholesterol antagonist
0,348  0,103  Antibacterial
0,339  0,097  Antipruritic, allergic
0,287  0,044  Chemopreventive
0,268  0,026  UGT1A3 substrate
0,279  0,040  Abortion inducer
0,246  0,009  Androgen antagonist
0,323  0,092  Antileukemic
0,248  0,018  Antifungal enhancer
0,241  0,011  Microtubule formation inhibitor
0,244  0,018  Protein-tyrosine phosphatase 1B inhibitor
0,234  0,010  Estrogen antagonist
0,336  0,116  Analgesic
0,274  0,064  NOS2 expression inhibitor
0,285  0,076  Antineoplastic (melanoma)
0,209  0,003  Glycine receptor antagonist
0,239  0,034  Protein-tyrosine phosphatase inhibitor
0,221  0,016  Arachidonic acid antagonist
0,250  0,045  Antialcoholic
0,248  0,044  Hepatoprotectant
0,272  0,070  Teratogen
0,290  0,092  Apoptosis antagonist
0,206  0,009  Estrogen receptor beta antagonist
0,205  0,009  Pregnane X receptor agonist
0,204  0,011  Contraceptive male
0,256  0,070  Antiprotozoal (Leishmania)
0,247  0,062  Antiparasitic
0,196  0,016  UGT2B1 substrate
0,250  0,072  Antineoplastic (liver cancer)
0,208  0,031  UGT2B10 substrate
0,211  0,035  Toxic, respiratory center
0,227  0,053  Neurotrophic factor enhancer
0,213  0,039  VEGF expression inhibitor
0,189  0,016  Antiinfertility, female
0,269  0,097  Caspase 3 stimulant
0,182  0,012  Opioid kappa receptor antagonist
0,275  0,107  Antineoplastic (small cell lung cancer)
0,200  0,033  Acetylcholinesterase inhibitor
0,186  0,021  Adenylate cyclase stimulant
0,188  0,025  Antifungal (Cryptococcus)
0,166  0,004  Narcotic antagonist
0,205  0,044  Cholinergic
0,239  0,080  Tumour necrosis factor alpha release inhibitor
0,212  0,054  Growth hormone agonist
0,275  0,118  Calcium channel activator
0,213  0,058  Age-related macular degeneration treatment
0,207  0,056  Antipruritic, non-allergic
0,261  0,112  Antihypertensive
0,189  0,041  Antidiarrheal
0,151  0,005  Acetyl-CoA transferase inhibitor
0,225  0,081  Embryotoxic
0,193  0,049  Phospholipase C inhibitor
0,149  0,005  Ca(v)3.1 blocker
0,158  0,014  Anabolic
0,155  0,013  Paget's disease treatment
0,190  0,051  Antirickettsial
0,297  0,160  Calcium channel L-type activator
0,242  0,108  Hypoxia-inducible factor 1 alpha inhibitor
0,181  0,050  Interferon gamma antagonist
0,134  0,003  Progesterone agonist
0,139  0,008  Na+ K+ transporting ATPase inhibitor
0,159  0,029  Choleretic
0,159  0,031  SULT1A1 substrate
0,221  0,093  Antihypercholesterolemic
0,147  0,021  Actinic keratosis treatment
0,210  0,086  Cyclic AMP phosphodiesterase inhibitor
0,192  0,071  Antihelmintic
0,140  0,020  UGT2B11 substrate
0,213  0,096  Cardiovascular analeptic
0,169  0,054  Antineoplastic (squamous cell carcinoma)
0,256  0,143  Immunosuppressant
0,165  0,054  Antiacne
0,118  0,010  Androgen agonist
0,152  0,048  DNA polymerase I inhibitor
0,184  0,084  Anesthetic general
0,203  0,105  Antipyretic
0,101  0,005  Glucocorticoid antagonist
0,149  0,053  Farnesoid X receptor antagonist
0,109  0,014  Anticholelithogenic
0,152  0,057  MAP3K9 inhibitor
0,214  0,119  Chemoprotective
0,199  0,107  Antineoplastic (non-small cell lung cancer)
0,118  0,031  SULT1E1 substrate
0,152  0,065  Antiparkinsonian, tremor relieving
0,209  0,123  Transcription factor STAT3 inhibitor
0,194  0,109  RNA-directed DNA polymerase inhibitor
0,155  0,071  Acute respiratory distress syndrome (ARDS) treatment
0,091  0,007  RNA-directed RNA polymerase stimulant
0,196  0,112  Antihypotensive
0,117  0,034  Lanosterol 14 alpha demethylase inhibitor
0,228  0,145  Interleukin 2 agonist
0,244  0,162  Antiobesity
0,143  0,062  Ca2+-transporting ATPase inhibitor
0,117  0,038  Opioid antagonist
0,133  0,054  Cholesterol synthesis inhibitor
0,085  0,009  Acetyl-CoA transferase 2 inhibitor
0,180  0,105  Antiparkinsonian, rigidity relieving
0,151  0,077  Antiviral (Herpes)
0,118  0,046  Toll-Like receptor 4 antagonist
0,187  0,116  Vasodilator
0,087  0,017  SULT2A1 substrate
0,165  0,095  P-glycoprotein inhibitor
0,265  0,196  Cyclophilin D inhibitor
0,265  0,196  Antidiabetic
0,171  0,102  Interleukin antagonist
0,127  0,061  Growth stimulant
0,171  0,105  Cardiodepressant
0,198  0,133  Cardioprotectant
0,101  0,038  Transcription factor NF kappa B stimulant
0,188  0,128  Immunostimulant
0,155  0,095  Carcinogenic
0,081  0,021  GABA receptor antagonist
0,094  0,034  Opioid mu receptor antagonist
0,076  0,016  Lipocortins synthesis agonist
0,079  0,022  GABA A receptor antagonist
0,120  0,063  Constipation treatment
0,184  0,128  Antioxidant
0,121  0,066  Adenylate cyclase inhibitor
0,060  0,005  Tubulin agonist
0,068  0,014  Liver X receptor agonist
0,077  0,024  Estrogen agonist
0,071  0,020  Postcoital contraceptive
0,067  0,016  Estrogen receptor beta agonist
0,069  0,018  Nicotinic alpha3beta2 receptor antagonist
0,062  0,013  Microtubule stabilization
0,065  0,016  Opioid kappa receptor agonist
0,140  0,092  Mutagenic
0,056  0,009  Glucose-6-phosphate dehydrogenase inhibitor
0,058  0,011  Farnesoid X receptor agonist
0,063  0,016  Adenylate cyclase 1 inhibitor
0,101  0,054  Prolactin inhibitor
0,082  0,036  Opioid delta receptor antagonist
0,168  0,124  Antineoplastic enhancer
0,067  0,028  Postmenopausal disorders treatment
0,061  0,022  11-Beta-hydroxysteroid dehydrogenase 1 inhibitor
0,176  0,138  DNA damaging
0,096  0,058  Bile acid receptor antagonist
0,100  0,063  Sulfotransferase substrate
0,198  0,161  Nootropic
0,052  0,015  Hypogonadism treatment
0,066  0,031  Heme oxygenase stimulant
0,122  0,092  Lipid peroxidase inhibitor
0,050  0,021  Parathyroid hormone antagonist
0,075  0,046  Glycine receptor agonist
0,187  0,161  Tyrosine 3 hydroxylase inhibitor
0,043  0,019  Estrogen receptor alpha agonist
0,076  0,054  Estrogen receptor alpha antagonist
0,199  0,178  Vasodilator, peripheral
0,061  0,040  Aromatase inhibitor
0,140  0,120  ATPase inhibitor
0,143  0,127  Antineoplastic (bone cancer)
0,097  0,082  GABA C receptor antagonist
0,019  0,005  Antibiotic Tetracycline-like
0,270  0,256  Ca2+/calmodulin-dependent protein kinase kinase A inhibitor
0,107  0,094  Tubulin antagonist
0,169  0,155  Radioprotector
0,139  0,126  Psychostimulant
0,050  0,037  H+/K+-transporting ATPase inhibitor
0,071  0,060  Analgesic, opioid
0,099  0,089  TRPA1 agonist
0,175  0,165  Antidiabetic (type 2)
0,066  0,057  Protein kinase C beta inhibitor
0,024  0,017  Protein 30S ribosomal subunit inhibitor
0,017  0,012  Telomerase stimulant
0,139  0,134  Death-associated protein kinase 2 inhibitor
0,026  0,021  11-Beta-hydroxysteroid dehydrogenase 2 inhibitor
0,042  0,037  Opioid mu receptor agonist
0,053  0,050  Bombesin 1 receptor agonist
0,047  0,044  Opioid agonist
0,108  0,107  Protein kinase stimulant
0,017  0,016  Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor
0,090  0,089  Endometrios treatment
0,131  0,130  Platelet adhesion inhibitor
0,098  0,098  Menstruation disorders treatment

